Viridian Cannabis Deal Tracker for Week Ended 1/13/17

Viridian Capital Advisors  |

Cannabis Training University via Wikimedia Commons

We saw the continuation of several trends in the cannabis capital markets during the week ended January 13, 2017: Canadian-licensed producers continue acquiring real estate to build out their cultivation capacity as well as clinic networks to boost patient access and retention; companies continue to seek additional capital and liquidity by listing on public stock exchanges, primarily those in the US and Canada; and investment funds are launched to attempt to seek returns from diversified portfolios of cannabis-related assets. Also, one of New York State's medical cannabis licensees, Bloomfield Industries, was sold to MedMen after facing financial troubles following the slow roll-out of New York's medical cannabis program.

Lawsuits: Twitter Settles Class Action for $809.5 Million Over Providing Misleading Information to Investors

Agriculture Technology
Arcturus Closes Initial Tranche for C$295,000


Biotech/Pharma
Veritas Announces Private Placement

Veritas Closes Private Placement

Nemus Bioscience Closes Preferred Stock Offering


Cultivation & Retail

Emerald Health Files Preliminary Base Shelf Prospectus

Valens GroWorks Closes Final Tranche of Offering


Infused Products & Extracts
CLS Holdings USA, Inc. Issues Convertible Notes


Physical Security
Helix TCS Amends Convertible Notes and Sells Shares for Cash


Real Estate
Zoned Properties Issues Convertible Debentures


Biotech/Pharma
Kalytera Therapeutics Enters into Binding Letter of Intent to Acquire Talent Biotechs and its Phase 2 Clinical-Stage Graft versus Host Disease Program

Bird Rock Bio Receives Approval to Start First in Human Clinical Trial for Namacizumab, Enters Into Agreement with GE Healthcare for Process Development and Scale-up to Provide Clinical Phase 2 cGMP Material, and Enters into a Collaboration and Option Agreement with Janssen Pharmaceuticals, Inc.


Cultivation & Retail
Mettrum Health Corp. to Acquire Bodystream Cannabis Clinic Network

Organigram Acquires Adjacent Property for Infused Products Manufacturing

TW Holding Ltd. Closes Takeover Bid for AusCann

California Firm, MedMen, Acquiring Bloomfield Industries in Medical Marijuana Shakeup

Hemp
True Leaf Completes Purchase of Award‐Winning Animal‐Care Product Company

Investments/M&A
Marapharm Ventures, Inc. Increases Its Investment Position in Veritas Pharma, Inc. to 15 Million Shares and Warrants

Marapharm Ventures, Inc. Invests in Veritas Pharma, Inc.

CannaRoyalty to Acquire 20% of Anandia Labs, a Leader in Cannabis Testing, Extraction, and Genetics

Biotech/Pharma
Tetra Bio-Pharma Inc. Enters into Binding Letter of Intent for Co-development and Commercialization of Health Care Products Containing Cannabinoids and Closes a Private Placement

Biotech/Pharma
Kalytera Therapeutics Begins Trading on the TSX Venture Exchange

Investments/M&A
The Canadian Bioceutical Corporation to List on the CSE and Delist from the TSXV

Biotech/Pharma
Kalytera Therapeutics Begins Trading on the TSX Venture Exchange

To Learn More About the Viridian CANNABIS DEAL TRACKER Contact:

Harrison Phillips
Viridian Capital Advisors, LLC
(212) 485-0284
hphillips@viridianca.com

* Viridian Capital Advisors and its affiliates, as well as their respective partners, directors, shareholders, and employees may have a position in the securities mentioned herein and may make purchases and/or sales from time to time. Viridian Capital Advisors, may act, or may have acted in the past, as a financial advisor, fiscal agent, or underwriter for certain of the companies mentioned herein and may receive, or may have received, a remuneration for their services from those companies.

About the Viridian CANNABIS DEAL TRACKER
The Viridian CANNABIS DEAL TRACKER monitors capital raise, mergers & acquisition, joint venture, and licensing activity for both public and private companies in the legal cannabis industry across 12 key sectors, including Agriculture Technology, Biotech/Pharma, Consulting Services, Consumption Devices, Cultivation & Retail, Hemp, Investments/M&A (Holding Companies), Infused Products & Extracts, Miscellaneous Ancillary, Physical Security, Real Estate, and Software/Media.

Leveraging more than 3 years of data that's been collected, segmented, and analyzed, the CANNABIS DEAL TRACKER supports smart decision-making by providing sector-specific actionable intelligence and trend analysis in regard to issuers, investors, acquirers, valuations, deal structures, and deal terms.

The above information whether in part or in its entirety neither constitutes an offer nor makes any recommendation to buy or sell any securities.

About Viridian Capital Advisors, LLC
Viridian Capital Advisors is a financial and strategic advisory firm dedicated to the cannabis market. We provide market intelligence, investment banking, investor relations, and corporate development services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, provides capital and M&A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team’s decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Market Movers

Sponsored Financial Content